| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.47B | +37.4% |
| Cost of Revenue | $7.27B | +35.2% |
| Gross Profit | $7.21B | +39.6% |
| R&D Expense | $1.83B | +66.6% |
| SG&A Expense | $766.0M | +15.9% |
| Operating Income | $1.82B | +76.3% |
| Pre-tax Income | $1.55B | +99.1% |
| Income Tax | $569.0M | +90.9% |
| Net Income | $987.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.56B | +33.8% |
| Short-term Investments | $3.48B | +48.8% |
| Accounts Receivable | $156.0M | +20.0% |
| Inventory | $238.0M | +56.6% |
| Current Assets | $14.29B | +30.5% |
| Total Assets | $17.65B | +28.5% |
| Current Liabilities | $11.30B | +31.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.14B | +74.8% |
| Capital Expenditures | $509.0M | +12.1% |
| Investing Cash Flow | -$3.45B | +10.9% |
| Financing Cash Flow | -$267.0M | -129.1% |
| Free Cash Flow | $4.63B | +86.3% |
| +104.8% |
| EPS (Basic) | $19.64 | +105.2% |
| EPS (Diluted) | $19.46 | +104.2% |
| Long-term Debt |
| $4.50B |
| -5.5% |
| Total Liabilities | $14.57B | +22.4% |
| Stockholders' Equity | $3.07B | +68.1% |